Worcester Life Science Hub to Receive MassBio’s Leading Impact Award
Wednesday, March 13, 2013
“We are honored,” said Kevin O’Sullivan, MBI’s President and CEO, who will accept the award this Thursday at MassBio’s Annual Meeting at the Royal Sonesta Hotel in Cambridge.
The Leading Impact Award was developed by MassBio’s Economic Development Advisory Group (EDAG) to recognize significant contributions made by innovative organizations each year within the industry, and in the arena of property development and local, regional, and state economic development, that have successfully worked to improve the ecosystem for industry growth in Mass.
“MBI has fostered entrepreneurship and life sciences startups in MA for almost three decades, helping dozens of companies to become established and to grow,” said Mark R. Bamforth, EDAG Chairman and President & CEO of Gallus Pharmaceuticals. “It took foresight and courage to create a biotech hub in Worcester which complements the growth of the industry in Cambridge and around the Commonwealth. Kevin O’Sullivan has been a stalwart advocate for strong regional growth.”
“We’ve progressed quite well,” said O’Sullivan. “People didn’t even know what life sciences were 25 years ago.”
Founded in 1985, MBI in Worcester is a private, independent economic development organization dedicated to job creation and innovative healthcare throughout Massachusetts by promoting the growth of start-up biomedical companies. MBI operates three life science business incubator facilities in Worcester that are home to twenty companies with approximately 100 employees.
“Our goal is to bring emerging companies in and eventually send them out on their own to be successful.” said O’Sullivan.
MBI achieves this through its incubator facilities, by providing cost-effective, high quality laboratory space and support services.
“The Leading Edge Award is a great tribute to our entrepreneurial MBI tenant companies - past and present, who commercialize their science by way of creating innovative companies and jobs while in turn helping to grow our Massachusetts economy,” O’Sullivan said. “We are grateful to MassBio for this recognition and look forward to continuing to work with them in fulfilling our economic mission.”
The City of Worcester nominated MBI for this award and it is the second company to be honored with it by MassBio.
“MBI was and remains instrumental in establishing Worcester as a premier biotechnology center,” said Timothy J. McGourthy, Chief Development Officer of the City of Worcester. “Under Kevin O’Sullivan’s leadership MBI has become a center for collaboration and innovation. MBI’s promotion of new start-ups, institutional partnerships, and tireless advocacy is transforming the future of healthcare worldwide as well as stimulating job growth in Worcester and throughout the Commonwealth.”
“We have been very successful so far,” said O’Sullivan. “And we keep looking to the future.”
- NEW: UMass Medical School Finds New Partner for Biomedical Innovation
- NEW: UMass Med to Seek Taxable Tenants For Biotech Park
- NEW: Patrick to Unveil $400 Million Biomed Facility at UMass Med School
- Worcester Continues Reputation As Hotspot For Biotech Innovation
- Tech Start Ups Move Out of Worcester to Find Funding
- Tech is Destroying the Line Between Manufacturing and Services
- NEW: WPI on the Cutting Edge of Tracking Technology
- O’Sullivan to Lead United Way Annual Campaign
- Marlborough Firm’s Laser Technology to Keep Troops Safe From IEDs